Tag: Lexicon Pharmaceuticals

RELIEF-DPN-1 clinical trial : Lexicon begins patient dosing with LX9211

pharmanewsdaily- September 6, 2020 0

RELIEF-DPN-1 clinical trial : Lexicon Pharmaceuticals has started patient dosing in a phase 2 trial of LX9211 for the treatment of diabetic peripheral neuropathic pain. ... Read More

Lexicon’s Xermelo gets FDA approval to treat carcinoid syndrome diarrhea

pharmanewsdaily- March 1, 2017 0

Lexicon Pharmaceuticals’ oral drug Xermelo (telotristat ethyl) 250mg has been approved in combination with somatostatin analog (SSA) therapy by the US Food and Drug Administration ... Read More